Mucopolysaccharidosis Type VII clinical trials at UCSF
1 research study open to eligible people
open to eligible females ages 18-50
The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.
San Francisco, California
Our lead scientists for Mucopolysaccharidosis Type VII research studies include Tippi Mackenzie.